This therapy is one of a few drugs in mid-to-late-stage development for Parkinson’s that has displayed disease-modifying ...

Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

A new study suggests that one of the most common diabetes treatments may speed type 2 diabetes progression by causing insulin-producing cells to lose their functional identity. Sulphonylureas have bee ...

The Linac Coherent Light Source in California has been firing record-breaking X-ray pulses for years, but now it’s due for a ...

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...

A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic ...

A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a ...

Roche’s FDA approval of Lunsumio VELO as a one-minute subcutaneous bispecific therapy for relapsed or refractory follicular lymphoma marks a meaningful advance in reducing treatment burden while ...

Winston-Salem's Innovation Quarter enjoyed a year of expansion in 2025. Plans are now in place to enter Phase II of its ...

WORK Medical Technology Group LTD (Nasdaq: WOK) ('WORK Medical”, the 'Company” or 'we”), a supplier of medical devices in ...

WORK Medical Technology Group LTD (Nasdaq: WOK) ('WORK Medical” or the 'Company”), a supplier of medical devices in China, ...

A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...